EGFR and lung cancer: Nonsquamous non‐small cell lung cancers (NSCLC) account for approximately 65% of lung cancers in men and 85% of lung cancers in women; 30%–40% of these have mutations in the epidermal growth factor receptor (EGFR) gene in patients in Asia.1